Highlights
- Bcal Diagnostics Ltd (ASX: BDX) closed at $0.065 on August 7, 2026.
- The stock recorded a decline of approximately 1.52 percent for the session.
- Shares traded within an intraday range of $0.065 to $0.067.
- Market capitalisation stood at approximately $23.96 million.
- Trading volume reached 20,062 shares during the session.
Bcal Diagnostics Ltd (ASX: BDX) shares closed at $0.065 on August 7, 2026, after recording a decline of approximately 1.52 percent during the session. The stock traded between an intraday low of $0.065 and a high of $0.067, while the broader S&P/ASX 200 Health Care Index ended lower.
Bcal Diagnostics Share Price Movement on August 7, 2026
The data reviewed showed that Bcal Diagnostics shares recorded a decline of approximately 1.52 percent during the session. The stock traded between an intraday low of $0.065 and a high of $0.067 before closing at $0.065.
The session reflected a narrow trading range, with the closing price remaining close to the day’s low. Daily share price movements can be influenced by company-specific developments, trading participation, sector sentiment and broader market conditions.
Trading Volume and Market Capitalisation
Trading volume for Bcal Diagnostics reached 20,062 shares during the session. Based on the closing share price, the company’s market capitalisation stood at approximately $23.96 million.
The trading activity reflected market participation during the session, while the company’s market capitalisation placed Bcal Diagnostics among the smaller-capitalisation companies within the ASX health care sector.
One-Year Share Price Performance
Over the trailing one-year period, Bcal Diagnostics recorded an increase of approximately 4.84 percent based on the data reviewed.
Smaller health care companies can experience changes in share price over time due to company-specific developments, market expectations, trading liquidity, sector conditions and broader investor sentiment.
ASX Health Care Sector Performance
The broader S&P/ASX 200 Health Care Index (XHJ) closed at 27,976.2 points on August 7, 2026, down 259.3 points or 0.92 percent.
The index recorded a day high of 28,235.5 points and a day low of 27,808.8 points, compared with a previous close of 28,235.5 points. Over the past 52 weeks, the index traded between 21,947.2 and 45,579.6 points, with a one-year return of negative 37.44 percent.
Individual health care stocks can record movements that differ from the broader index due to company-specific factors, trading volumes and changes in investor participation.
About Bcal Diagnostics Ltd
Bcal Diagnostics Ltd is listed on the ASX under the ticker code BDX and operates within the health care sector.
Companies operating in the diagnostics and health care technology segments can experience share price movements influenced by company developments, industry conditions, sector sentiment and broader market trends.
Understanding the Trading Data
The share price, trading volume and market capitalisation figures provide an overview of Bcal Diagnostics’ market activity during the reviewed session.
Trading volume represents the number of shares exchanged during the session, while market capitalisation reflects the market value based on the closing share price and shares on issue. Daily price movements represent activity during a specific trading period and do not necessarily indicate longer-term performance.
Conclusion
Bcal Diagnostics Ltd (ASX: BDX) shares closed at $0.065 on August 7, 2026, after recording a decline of approximately 1.52 percent during the session. The stock traded within a range of $0.065 to $0.067, with trading volume of 20,062 shares and market capitalisation of approximately $23.96 million.
The broader S&P/ASX 200 Health Care Index closed lower at 27,976.2 points, down 0.92 percent. Over the trailing one-year period, Bcal Diagnostics recorded an increase of approximately 4.84 percent based on the data reviewed.
_11_17_2026_06_50_14_402066.jpg)





Please wait processing your request...